Delirium Clinical Trials

Find Delirium Clinical Trials Near You

Enhanced Continuity of Postoperative Care for Older People in Their Neurocognitive Recovery After Cardiac Surgery

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Society is aging and advantages in anesthesia and surgery allow more complex interventions in older persons. Old age is a significant risk factor for the development of postoperative neurocognitive decline characterized by a gradual decrease in performance in several cognitive domains such as memory, attention, information processing, and executive functions, leading to problems with performing daily activities and maintaining independence and postoperative complications. The purpose of this study is to measure older persons' postoperative neurocognitive function, to detect neurocognitive decline, and to identify risk factors and difficulties in daily living as well as explore close relatives' experiences of it. We will include 220 participants ≥65 years of age undergoing planned cardiac surgery. Cognitive symptoms and signs and neurocognitive function will be assessed up to 6 months after surgery. Risk/affected factors such as delirium, functional status, recovery, depression, and healthcare-related quality of life, as well as close relative's experiences and burden, will be measured. The results will have immediate relevance for a substantial number of older persons undergoing surgery, and their close relatives, by enhancing knowledge about postoperative cognitive decline and recovery, and subsequently identifying what support needs to be implemented.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: f
View:

• Scheduled for elective or urgent open-heart surgery or minimally invasive cardiac surgery

• Resident in the area/region for the current thoracic clinic

• Able to read and understand Swedish

Locations
Other Locations
Sweden
Sahlgrenska University Hospital
RECRUITING
Gothenburg
Contact Information
Primary
Lina Bergman, PhD
lina.bergman@ki.se
0046 8 524 836 66
Backup
Ulrica Nilsson, Professor
ulica.nilsson@ki.se
Time Frame
Start Date: 2024-11-01
Estimated Completion Date: 2027-12
Participants
Target number of participants: 220
Related Therapeutic Areas
Sponsors
Leads: Karolinska Institutet
Collaborators: Sahlgrenska University Hospital

This content was sourced from clinicaltrials.gov